80_FR_80158 80 FR 79912 - Agency Information Collection Activities: Proposed Collection; Comment Request; Bar Code Label Requirement for Human Drug and Biological Products; Correction

80 FR 79912 - Agency Information Collection Activities: Proposed Collection; Comment Request; Bar Code Label Requirement for Human Drug and Biological Products; Correction

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 80, Issue 246 (December 23, 2015)

Page Range79912-79912
FR Document2015-32252

The Food and Drug Administration (FDA) is correcting a notice entitled ``Agency Information Collection Activities: Proposed Collection; Comment Request; Bar Code Label Requirement for Human Drug and Biological Products'' that appeared in the Federal Register of December 15, 2015 (80 FR 77637). The document solicited comments on the bar code label requirements for human drug and biological products. The document was published with an incorrect docket number. This document corrects that error.

Federal Register, Volume 80 Issue 246 (Wednesday, December 23, 2015)
[Federal Register Volume 80, Number 246 (Wednesday, December 23, 2015)]
[Notices]
[Page 79912]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-32252]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0873]


Agency Information Collection Activities: Proposed Collection; 
Comment Request; Bar Code Label Requirement for Human Drug and 
Biological Products; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
entitled ``Agency Information Collection Activities: Proposed 
Collection; Comment Request; Bar Code Label Requirement for Human Drug 
and Biological Products'' that appeared in the Federal Register of 
December 15, 2015 (80 FR 77637). The document solicited comments on the 
bar code label requirements for human drug and biological products. The 
document was published with an incorrect docket number. This document 
corrects that error.

FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy and 
Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 
32, rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.

SUPPLEMENTARY INFORMATION: In the Federal Register of Tuesday, December 
15, 2015, in FR Doc. 2015-31402, the following correction is made:
    1. On page 77637, in the second column, the docket number is 
corrected to read FDA-2012-N-0873.

    Dated: December 15, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-32252 Filed 12-22-15; 8:45 am]
BILLING CODE 4164-01-P



                                              79912                             Federal Register / Vol. 80, No. 246 / Wednesday, December 23, 2015 / Notices

                                                                                                TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued
                                                                                                                                                          Number of re-
                                                                                                                                       Number of                             Total annual     Average burden per
                                                                                 Activity                                                                  sponses per                                                           Total hours
                                                                                                                                      respondents                             responses            response
                                                                                                                                                            respondent

                                              Pretest ..........................................................................                 640                    1              640       0.75 (45 minutes)                        480
                                              Main Study Screener ...................................................                          2,112                    1            2,112        0.08 (5 minutes)                        169
                                              Main Study ...................................................................                   1,056                    1            1,056       0.75 (45 minutes)                        792

                                                    Total ......................................................................               5,193                    1            5,193    ................................          1,560
                                                 1 There     are no capital costs or operating and maintenance costs associated with the collection of information.


                                              V. References                                                                   CFRSearch.cfm?fr=202.1)                              DEPARTMENT OF HEALTH AND
                                                                                                                         10. Wingfield A., L.W. Poon, L. Lombardi, D.              HUMAN SERVICES
                                                The following references are on
                                                                                                                              Lowe. ‘‘Speed of Processing in Normal
                                              display in the Division of Dockets
                                                                                                                              Aging: Effects of Speech Rate, Linguistic            Food and Drug Administration
                                              Management (HFA–305), Food and Drug
                                                                                                                              Structure, and Processing Time.’’ The
                                              Administration, 5630 Fishers Lane, Rm.
                                                                                                                              Journals of Gerontology. 40(5):579–85,
                                              1061, Rockville, MD 20852, and are                                                                                                   [Docket No. FDA–2012–N–0873]
                                                                                                                              1985.
                                              available for viewing by interested                                        11. Kramer A.F., S. Hahn, D. Gopher. ‘‘Task
                                              persons between 9 a.m. and 4 p.m.,                                                                                                   Agency Information Collection
                                                                                                                              Coordination and Aging: Explorations of
                                              Monday through Friday; they are also                                                                                                 Activities: Proposed Collection;
                                                                                                                              Executive Control Processes in the Task
                                              available electronically at http://                                                                                                  Comment Request; Bar Code Label
                                                                                                                              Switching Paradigm.’’ Acta
                                              www.regulations.gov. FDA has verified                                           Psychologica. 101:339–78, 1999.
                                                                                                                                                                                   Requirement for Human Drug and
                                              the Web site addresses, as of the date                                     12. Naveh-Benjamin M., J. Guez, A. Kilb, S.               Biological Products; Correction
                                              this document publishes in the Federal                                          Reedy. ‘‘The Associative Memory Deficit
                                              Register, but Web sites are subject to                                          of Older Adults: Further Support Using               AGENCY:     Food and Drug Administration,
                                              change over time.                                                               Face-Name Associations.’’ Psychology                 HHS.
                                              1. Zhong W., H. Maradit-Kremers, J.L. St.                                       and Aging. 19(3):541–6, 2004.
                                                   Sauver, et al., ‘‘Age and Sex Patterns of                                                                                       ACTION:    Notice; correction.
                                                                                                                         13. Sommers M.S., N. Tye-Murray, B. Spehar.
                                                   Drug Prescribing in a Defined American
                                                   Population.’’ Mayo Clinic Proceedings.                                     ‘‘Auditory-Visual Speech Perception and              SUMMARY:   The Food and Drug
                                                   88(7):697–707, 2013.                                                       Auditory-Visual Enhancement in
                                                                                                                                                                                   Administration (FDA) is correcting a
                                              2. Depp C.A., D.A. Schkade, W.K. Thompson,                                      Normal-Hearing Younger and Older
                                                                                                                                                                                   notice entitled ‘‘Agency Information
                                                   D.V. Jeste. ‘‘Age, Affective Experience,                                   Adults.’’ Ear and Hearing. 26(3):263–75,
                                                   and Television Use.’’ American Journal                                     2005.
                                                                                                                                                                                   Collection Activities: Proposed
                                                   of Preventative Medicine. 39:173–8,                                   14. Watson J.M., K.B. McDermott, D.A.                     Collection; Comment Request; Bar Code
                                                   2010.                                                                      Balota. ‘‘Attempting to Avoid False                  Label Requirement for Human Drug and
                                              3. Agrawal Y., E.A. Platz, J.K. Niparko.                                        Memories in the Deese/Roediger-                      Biological Products’’ that appeared in
                                                   ‘‘Prevalence of Hearing Loss and                                                                                                the Federal Register of December 15,
                                                   Differences by Demographic                                                 McDermott Paradigm: Assessing the
                                                   Characteristics Among US Adults.’’                                         Combined Influence of Practice and                   2015 (80 FR 77637). The document
                                                   Archives of Internal Medicine.                                             Warnings in Young and Old Adults.’’                  solicited comments on the bar code
                                                   168(14):1522–30, 2008.                                                     Memory and Cognition. 32(1):135–41,                  label requirements for human drug and
                                              4. Cruickshanks K.J., T.L. Wiley, T.S. Tweed,                                   2004.                                                biological products. The document was
                                                   et al., ‘‘Prevalence of Hearing Loss in                               15. Gates G.A., M.P. Feeney, D. Mills. ‘‘Cross-           published with an incorrect docket
                                                   Older Adults in Beaver Dam,                                                Sectional Age-Changes of Hearing in the              number. This document corrects that
                                                   Wisconsin.’’ American Journal of                                           Elderly.’’ Ear and Hearing. 29(6):865–74,
                                                   Epidemiology. 148(9):879–86, 1998.                                                                                              error.
                                                                                                                              2008.
                                              5. Lin FR, R. Thorpe, S. Gordon-Salant, L.
                                                   Ferrucci. ‘‘Hearing Loss Prevalence and                               16. Morrell C.H., S. Gordon-Salant, J.D.                  FOR FURTHER INFORMATION CONTACT:    Lisa
                                                   Risk Factors Among Older Adults in the                                     Pearson, L.J. Brant, J.L. Fozard. ‘‘Age-             Granger, Office of Policy and Planning,
                                                   United States.’’ The Journals of                                           and Gender-Specific Reference Ranges                 Food and Drug Administration, 10903
                                                   Gerontology Series A: Biological                                           for Hearing Level and Longitudinal                   New Hampshire Ave., Bldg. 32, rm.
                                                   Sciences and Medical Sciences.                                             Changes in Hearing Level.’’ Journal of               3330, Silver Spring, MD 20993–0002,
                                                   66A(5):582–90, 2011.                                                       the Acoustical Society of America.                   301–796–9115.
                                              6. Garstecki DC, S.F. Erler. ‘‘Hearing Loss,                                    100(4)Pt. 1:1949–67, 1996.
                                                   Control, and Demographic Factors                                      17. Cutler A., D. Dahan, W. van Donselaar.                SUPPLEMENTARY INFORMATION:    In the
                                                   Influencing Hearing Aid Use Among                                          ‘‘Prosody in the Comprehension of                    Federal Register of Tuesday, December
                                                   Older Adults.’’ Journal of Speech,
                                                   Language, and Hearing Research.
                                                                                                                              Spoken Language: A Literature Review.’’              15, 2015, in FR Doc. 2015–31402, the
                                                   41:527–37, 1998.                                                           Language and Speech. 40(2):141–201,                  following correction is made:
                                              7. Gates G.A., J.C. Cooper. ‘‘Incidence of                                      1997.                                                  1. On page 77637, in the second
                                                   Hearing Decline in the Elderly.’’ Acta                                  Dated: December 15, 2015.                               column, the docket number is corrected
                                                   Oto-laryngol. 111:240–8, 1991.
                                                                                                                         Leslie Kux,                                               to read FDA–2012–N–0873.
tkelley on DSK3SPTVN1PROD with NOTICES




                                              8. Humes L.E. ‘‘Speech Understanding in the
                                                   Elderly.’’ Journal of the American                                    Associate Commissioner for Policy.                          Dated: December 15, 2015.
                                                   Academy of Audiology. 7:161–7, 1996.                                  [FR Doc. 2015–32251 Filed 12–22–15; 8:45 am]              Leslie Kux,
                                              9. U.S. Food and Drug Administration. Code
                                                                                                                         BILLING CODE 4164–01–P                                    Associate Commissioner for Policy.
                                                   of Federal Regulations. Prescription drug
                                                   advertisements, 21 CFR Sect. 202.1.                                                                                             [FR Doc. 2015–32252 Filed 12–22–15; 8:45 am]
                                                   2013. (http://www.accessdata.fda.gov/                                                                                           BILLING CODE 4164–01–P
                                                   scripts/cdrh/cfdocs/cfCFR/



                                         VerDate Sep<11>2014         18:05 Dec 22, 2015         Jkt 238001      PO 00000           Frm 00096   Fmt 4703   Sfmt 9990   E:\FR\FM\23DEN1.SGM    23DEN1



Document Created: 2018-03-02 09:21:39
Document Modified: 2018-03-02 09:21:39
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice; correction.
ContactLisa Granger, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.
FR Citation80 FR 79912 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR